Neuren Pharmaceuticals
Latest round
- Series A
Last raised
- Aug 2000
Total raised
- Undisclosed
Investors
- 2
About Neuren Pharmaceuticals
Founded in 2000 and headquartered in Melbourne, Australia, Neuren Pharmaceuticals Limited develops therapies for neurodevelopmental disorders. The company has undergone strategic pivots, including its focus on NNZ-2591, designed to address conditions like Pitt-Hopkins syndrome.Neuren Pharmaceuticals Limited focuses on the development of innovative therapeutics targeting neurodevelopmental disabilities. Their core products include NNZ-2591, designed to treat conditions such as Pitt-Hopkins syndrome by modulating neuroinflammation and promoting synaptic function. Neuren is actively involved in clinical trials to establish the efficacy and safety of its products, targeting healthcare providers and institutions in pediatric neurology and developmental disorders.55 mn. The company intends to penetrate new markets, particularly in North America and Europe, by late 2024.
Who invested in Neuren Pharmaceuticals
2 investors across 1 round
See all investors in Neuren Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 4, 2000
Amount
Undisclosed
Investors
Questions about Neuren Pharmaceuticals
Who invested in Neuren Pharmaceuticals?
Neuren Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuren Pharmaceuticals raised?
Neuren Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neuren Pharmaceuticals last raise money?
Neuren Pharmaceuticals's most recent round on record is a Series A, in Aug 2000.
What does Neuren Pharmaceuticals do?
Founded in 2000 and headquartered in Melbourne, Australia, Neuren Pharmaceuticals Limited develops therapies for neurodevelopmental disorders.
Where is Neuren Pharmaceuticals headquartered?
Neuren Pharmaceuticals is headquartered in Melbourne, Australia.
Which VCs invest in companies like Neuren Pharmaceuticals?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Neuren Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Neuren Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.